Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction
Akira Funada(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Takuya Hasegawa(Tokyo Institute of Technology), Hiromi Hashimura(National Cerebral and Cardiovascular Center), Teruo Noguchi(National Cerebral and Cardiovascular Center), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Yoshiaki Morita(Osaka City University), Masafumi Kitakaze(Hanwa Memorial Hospital), Yasuo Sugano(keiyu Hospital), Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Satoshi Yasuda(Tohoku University)
Cited by 22
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k